Curis, Inc. to Present at Maxim Group Growth Conference 2009

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Maxim Group Growth Conference 2009 at 3:30 p.m. EDT on September 29, 2009, at the Grand Hyatt Hotel in New York City.

Back to news